BERMAN ROBERT ANDREW (Chief Executive Officer) purchased 53.5% of their position (2K shares) of ENVVENO MEDICAL CORP on the open market
Open‑market purchase worth $15.7K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/18/2021ACC: 0001493152-21-029229
DirectorOfficer· Chief Executive Officer
Since Sep 2018
+2K
Net shares
Net buyer
$15.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2K
Price / share
$7.87
Trade value
$15.74K
% of position
53.5%
11/16/2021
3.74K→5.74K
Total
Net shares
+2K
Net value
$15.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/16/2021 | P · Purchase | +2K | $7.87 | $15.74K | 53.5% | 3.74K | 5.74K |
| Total | +2K | $15.74K | ||||||
Derivative Transactions0
No derivative transactions reported